Mode
Text Size
Log in / Sign up

Serum 25(OH)D, AQP4, and IL-4 levels tracked after traumatic brain injuryLow Vitamin D Linked to Worse Brain Swelling After Injury

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider serum 25(OH)D on day 1 as a potential prognostic indicator in TBI, noting observational limitations.

This observational cohort study enrolled 279 patients with traumatic brain injury (TBI) during hospital admission between January 2023 and December 2024. Researchers measured serum 25(OH)D, AQP4, and IL-4 levels on days 1, 3, and 7 post-admission and compared a favorable outcome group (n=215) to a poor outcome group (n=64) based on 90-day follow-up.

Main results showed serum 25(OH)D levels were highest on day 1 post-TBI and decreased over time (P < 0.05). AQP4 and IL-4 levels were lowest on day 1 and increased significantly by days 3 and 7 (P < 0.05). An inverse correlation was found between serum 25(OH)D and brain edema volume (P < 0.05), while AQP4 and IL-4 levels showed a positive correlation with edema volume (P < 0.05).

In the favorable vs poor outcome groups, serum 25(OH)D levels were higher on days 1, 3, and 7 (P < 0.05), while AQP4 and IL-4 levels were lower (P < 0.05). Multivariate analysis indicated serum 25(OH)D on day 1 and Glasgow Coma Scale score were associated with favorable outcomes, whereas IL-4 levels on day 1 independently predicted poor prognosis (P < 0.05). ROC analysis suggested all tested biomarkers had prognostic value, with serum 25(OH)D on day 1 showing the highest predictive accuracy.

No adverse events, serious adverse events, discontinuations, or tolerability data were reported. Key limitations include the observational design, which cannot establish causation; the single-center setting, which may limit generalizability; and the lack of a control group for interventions. Practice relevance suggests serum 25(OH)D levels on day 1 post-injury may serve as a prognostic indicator for TBI outcomes, but findings are based on associations and should not guide interventions.

  • Low vitamin D tied to more brain swelling after trauma
  • Could help doctors predict recovery in brain injury patients
  • Not a treatment yet — still in early research stages

This simple blood test may help predict how well someone recovers after a head injury.

It starts with a fall, a crash, or a blow to the head. The person is rushed to the hospital. Doctors scan the brain, check vital signs, and brace for what comes next. But one big question lingers: Will they recover — or face lasting damage?

Right now, that answer is often unclear. But a new study suggests a clue might be hiding in plain sight — in a routine blood test for vitamin D.

Traumatic brain injury (TBI) affects millions every year. It can happen in car crashes, sports, falls, or combat. Even mild cases can lead to long-term problems — memory loss, mood changes, trouble thinking.

Severe TBI often causes brain swelling, called edema. Too much swelling can press on vital brain areas. That can lead to coma or death.

Doctors use tools like the Glasgow Coma Scale to guess how someone might do. But they need better ways to predict outcomes early.

Current treatments focus on reducing pressure — like draining fluid or cooling the brain. But they don’t always work. And they come too late for some.

We need earlier clues. Better warnings. That’s where this study comes in.

The surprising shift

For years, scientists have studied brain swelling by looking at injured brain tissue. They’ve focused on proteins like aquaporin-4 (AQP4), which acts like a water channel in brain cells.

Think of AQP4 as a gate that lets fluid in and out. After injury, these gates can go into overdrive — letting in too much water and causing swelling.

Another player is interleukin-4 (IL-4), a signaling protein tied to inflammation. High levels may make swelling worse.

But here’s the twist: vitamin D might be quietly fighting back.

What scientists didn’t expect

Vitamin D isn’t just for bones. It also plays a role in brain health and immune control.

This study found something striking: patients with higher vitamin D levels right after injury had less brain swelling.

And they were more likely to recover well.

It’s like vitamin D acts as a brake on the swelling process.

This doesn’t mean this treatment is available yet.

Imagine the brain after injury like a city after a storm. Water starts pooling in the streets. AQP4 channels are like broken drains — they let too much water in.

IL-4 is like a worker shouting, “Bring more water!” — making things worse.

But vitamin D? It’s like a calm voice saying, “Slow down. Close some gates.”

It may help control AQP4 and reduce harmful inflammation.

The result? Less fluid buildup. Less pressure. A better chance to heal.

The study followed 279 people with traumatic brain injury. Blood tests measured vitamin D, AQP4, and IL-4 levels on days 1, 3, and 7.

Brain scans tracked swelling.

After 90 days, doctors checked recovery. They split patients into two groups: those who did well and those who didn’t.

On day one, patients with more vitamin D had less brain swelling.

They were also more likely to have a good recovery three months later.

Those with low vitamin D had higher levels of AQP4 and IL-4 — the swelling-linked proteins.

They faced a much higher risk of long-term disability or death.

Vitamin D levels on day one were the strongest predictor of outcome — even better than some standard tools.

That’s not the full story.

Even more telling: high IL-4 levels on day one predicted poor recovery — no matter what else was going on.

This suggests inflammation kicks in fast after brain injury. And it may set the course early.

But vitamin D appears to help tilt the balance in the patient’s favor.

This study adds to growing evidence that vitamin D plays a role beyond bone health.

It fits with past research linking low vitamin D to worse outcomes in stroke, MS, and other brain conditions.

Experts say it’s too soon to change treatment. But it highlights the importance of checking vitamin D — especially in high-risk patients.

If you or a loved one suffers a head injury, doctors may already run a vitamin D test. This study supports doing so — not to treat, but to better understand risk.

It’s not a green light to start high-dose supplements after injury. That could be dangerous without proof.

But it does suggest keeping vitamin D levels healthy before an accident might help the brain respond better.

Talk to your doctor about checking your levels — especially if you’re at risk for falls or head trauma.

The hidden weakness

The study looked at one group in a single time period. It shows a link — not proof that low vitamin D causes worse swelling.

Patients weren’t randomly given vitamin D, so we can’t say supplements would help.

Also, all participants were from one region. Sunlight, diet, and genetics vary worldwide — so results might differ elsewhere.

What happens next

Researchers need to test whether giving vitamin D soon after injury improves outcomes.

Future trials could give IV vitamin D to TBI patients in the first hours. Then track swelling and recovery.

That kind of study would take years. But if it works, a simple, low-cost fix could one day become standard care.

For now, the message is clear: vitamin D may be more important for brain health than we thought.

And the first day after injury might be the most critical window of all.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveThis study aims to explore the associations between serum 25-hydroxyvitamin D (25(OH)D), aquaporin 4 (AQP4), and interleukin-4 (IL-4) levels with brain edema volume and outcomes in patients with traumatic brain injury (TBI).MethodsA cohort of 279 TBI patients, enrolled between January 2023 and December 2024, was analyzed. Serum levels of 25(OH)D, AQP4, and IL-4, as well as brain edema volume, were measured on days 1, 3, and 7 post-admission. Pearson correlation analysis was used to assess relationships between these serum markers and brain edema volume. Based on the 90-day follow-up outcome, patients were classified into a favorable outcome group (n = 215) and a poor outcome group (n = 64). Multivariate logistic regression was employed to identify factors influencing TBI outcomes.ResultsSerum 25(OH)D levels were highest on day 1 post-TBI, followed by day 3 and day 7 (P < 0.05). In contrast, AQP4 and IL-4 levels, along with brain edema volume, were lowest on day 1 and increased significantly by days 3 and 7 (P < 0.05). Serum 25(OH)D levels were inversely correlated with brain edema volume, while AQP4 and IL-4 levels exhibited a positive correlation (P < 0.05). On days 1, 3, and 7, the favorable outcome group had higher serum 25(OH)D levels and lower AQP4 and IL-4 levels compared to the poor outcome group (P < 0.05). Multivariate analysis revealed that serum 25(OH)D on day 1 and the Glasgow Coma Scale (GCS) score were associated with favorable outcomes, whereas IL-4 levels on day 1 independently predicted poor prognosis (P < 0.05). ROC curve analysis demonstrated that all tested biomarkers had prognostic value, with serum 25(OH)D on day 1 showing the highest predictive accuracy.ConclusionSerum levels of 25(OH)D, AQP4, and IL-4 are significantly associated with brain edema volume in TBI patients. Among these markers, serum 25(OH)D levels on the first day post-injury serve as the most reliable prognostic indicator of patient outcomes.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.